NetworkNewsBreaks – ChineseInvestors.com, Inc. (
Post# of 346
(Total Views: 162)
Posted On: 09/04/2018 5:56:38 PM
NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Records Significant Revenue Growth in FY2018 Financial Results
ChineseInvestors.com, Inc. (OTCQB: CIIX), the premier financial information website for Chinese-speaking investors, this morning announced its financial results for fiscal year 2018, as well as its outlook for fiscal year 2019 as the company continues its operations through both financial services and consumer products business segments. Per the update, the company’s gross operating revenues for the fiscal year ended May 31, 2018, were up 41 percent year-over-year, an increase that CIIX attributed to consumer product sales through its ChineseHempOil.com Inc. and CBD Biotechnology Co., Ltd. subsidiaries. “We have seen significant growth in revenue in the fiscal year ended May 31, 2018, which was largely attributed to our Company’s consumer product lines and our strategic focus on CBD hemp sales in China and within the Chinese community,” Warren Wang, CEO of CIIX, stated in the news release. “Looking forward, with our consumer products segment posting strong revenues and the regulatory climate appearing to lean in favor of legalizing hemp as an agricultural commodity, we intend to continue to expand our consumer division by dedicating more resources to marketing hemp-based CBD products both domestically and in China.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
ChineseInvestors.com, Inc. (OTCQB: CIIX), the premier financial information website for Chinese-speaking investors, this morning announced its financial results for fiscal year 2018, as well as its outlook for fiscal year 2019 as the company continues its operations through both financial services and consumer products business segments. Per the update, the company’s gross operating revenues for the fiscal year ended May 31, 2018, were up 41 percent year-over-year, an increase that CIIX attributed to consumer product sales through its ChineseHempOil.com Inc. and CBD Biotechnology Co., Ltd. subsidiaries. “We have seen significant growth in revenue in the fiscal year ended May 31, 2018, which was largely attributed to our Company’s consumer product lines and our strategic focus on CBD hemp sales in China and within the Chinese community,” Warren Wang, CEO of CIIX, stated in the news release. “Looking forward, with our consumer products segment posting strong revenues and the regulatory climate appearing to lean in favor of legalizing hemp as an agricultural commodity, we intend to continue to expand our consumer division by dedicating more resources to marketing hemp-based CBD products both domestically and in China.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Chineseinvestors.com Inc. (CIIX) Stock Research Links
Scroll down for more posts ▼